| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 12/11/2007 | US7307098 Indole derivatives and drugs containing the same |
| 12/11/2007 | US7307092 Compounds Capable of Activating Cholinergic Receptors |
| 12/11/2007 | US7307091 Deuterated 3-piperidinopropiophenone and medicaments containing said compounds |
| 12/11/2007 | US7307090 Piperidine derivatives useful as modulators of chemokine receptor activity |
| 12/11/2007 | US7307087 Antidepressants; analgesics; antiinflammatory agents; side effect reduction |
| 12/11/2007 | US7307082 Heterocyclic derivatives as CRF antagonists |
| 12/11/2007 | US7307080 Nuclear enzyme poly(adenosine 5'-diphospho-ribose) polymerase inhibitors; protection against ill effects of reactive free radicals and nitric oxide |
| 12/11/2007 | US7307079 Treating acute and chronic pain and inflammatory, gastrointestinal, allergic, cardiovascular, skin, opthalmological, respiratory, nervous system, cognition and memory disorders, etc. |
| 12/11/2007 | US7307075 Tetrahydroquinoline analogues as muscarinic agonists |
| 12/11/2007 | US7307073 Benzoxazepines derivatives and their use as AMPA receptor stimulators |
| 12/11/2007 | US7307062 such as anxiety disorder, attention deficit/hyperactivity disorder, autistic disorder, bipolar disorder, major depression, mood disorder, pervasive developmental disorder, psychotic disorder and schizophrenia by administering an antimicrobial composition optionally with a probiotic mixture |
| 12/11/2007 | US7306903 Use of test cells comprising DNA defining a morphogen-responsive transcription activating element operatively associated with reporter gene, increase in expression of detectable gene product after exposing test cell to candidate compound indicates ability of compound to induce morphogen-mediated effect |
| 12/11/2007 | US7306783 Complexing; drug delivery; in situ imaging; detection apoptosis |
| 12/11/2007 | CA2405822C Infant formulas containing long-chain polyunsaturated fatty acids and uses thereof |
| 12/11/2007 | CA2370202C Gum pad for delivery of medication to mucosal tissues |
| 12/11/2007 | CA2348735C Heterocyclic potassium channel inhibitors |
| 12/11/2007 | CA2304661C Parenteral formulations comprising carbamazepine or its derivatives |
| 12/11/2007 | CA2184077C Nasal and ocular administration of ketamine to manage pain and for detoxification |
| 12/06/2007 | WO2007139984A2 Duloxetine hcl polymorphs |
| 12/06/2007 | WO2007139826A2 Method for elevating prolactin in mammals |
| 12/06/2007 | WO2007139818A2 Pharmacological treatment of cognitive impairment |
| 12/06/2007 | WO2007139464A1 Isoindole derivatives useful for treating pain, gastrointestinal diseases and cancer |
| 12/06/2007 | WO2007139240A1 7-(3,4-dialkoxyphenyl)-pyrazolo[1,5-a]pyrimidine compounds, process for preparing thereof, and pharmaceutical composition for treating or preventing asthma, chronic obstructive pulmonary disease, arthritis, atopic dermatitis, tumor and degenerative brain diseases comprising the same |
| 12/06/2007 | WO2007139211A1 Process for production of optically active piperidine compound |
| 12/06/2007 | WO2007139178A1 Therapeutic agent for alzheimer's disease |
| 12/06/2007 | WO2007139153A1 Function-improving agent for cerebral dysfunction caused by environmental chemical |
| 12/06/2007 | WO2007139120A1 AMYLOID-β CLEARANCE ENHANCER |
| 12/06/2007 | WO2007139036A1 Compound for controlling endoplasmic reticulum stress, and pharmaceutical composition comprising the compound as active ingredient |
| 12/06/2007 | WO2007138994A1 Hsp90 inhibitor |
| 12/06/2007 | WO2007138810A1 Prophylactic/therapeutic agent for neurodegenerative disease |
| 12/06/2007 | WO2007138748A1 Pharmaceutical agent for recovery from fatigue |
| 12/06/2007 | WO2007138611A1 3-(heterocyclyl)-n-(arylsulfonyl)indole derivatives as functional 5-ht6 ligands |
| 12/06/2007 | WO2007138343A1 N-phenylamidines as 5-ht2a receptor antagonists |
| 12/06/2007 | WO2007138339A2 Treatment of pain by use of a single chain polypeptide fusion protein |
| 12/06/2007 | WO2007138336A2 Treatment of pain by single chain, polypeptide fusion protein |
| 12/06/2007 | WO2007138334A2 Methods for identifying an agent that modulates type i or type ii pip kinase activity or expression |
| 12/06/2007 | WO2007138322A1 New use for cannabinoid |
| 12/06/2007 | WO2007138301A2 Novel formulation |
| 12/06/2007 | WO2007138263A1 Prevention and/or treatment of neurodegenerative disorders |
| 12/06/2007 | WO2007138236A1 Sheddase enzymes for neuron growth |
| 12/06/2007 | WO2007138112A2 Compounds that interact with ion channels, in particular with ion channels from the kv family |
| 12/06/2007 | WO2007138086A1 Long term 24 hour intestinal administration of levodopa/carbidopa |
| 12/06/2007 | WO2007138081A1 PYRIMIDINO[1',6'-1,2]PYRIDO[3,4-b]INDOLE DERIVATIVES AND THEIR THERAPEUTIC USAGE |
| 12/06/2007 | WO2007138050A1 Sulphur containing pyrazole derivatives as selective cannabinoid cb1 receptor antagonists |
| 12/06/2007 | WO2007138041A1 Novel 1,4-diaza-bicyclo[3.2.2]nonyl pyrimidinyl derivative and its medical use |
| 12/06/2007 | WO2007138040A1 Novel 1,4-diaza-bicyclo[3.2.2]nonyl pyrimidinyl derivative and its medical use |
| 12/06/2007 | WO2007138039A1 Novel 1,4-diaza-bicyclo[3.2.2]nonyl pyrimidinyl derivatives and their medical use |
| 12/06/2007 | WO2007138038A1 Novel 1,4-diaza-bicyclo[3.2.2]nonyl oxadiazolyl derivatives and their medical use |
| 12/06/2007 | WO2007138037A1 Novel 1,4-diaza-bicyclo[3.2.2]nonyl oxadiazolyl derivatives and their medical use |
| 12/06/2007 | WO2007138033A1 2-phenyl-5-amino-1,3,4-oxadiazoles and their use as nicotinic acetylcholine receptor ligands |
| 12/06/2007 | WO2007137954A1 Aryl-4-ethynyl-isoxazole derivatives |
| 12/06/2007 | WO2007137953A1 Benzazepine derivatives as monoamine reuptake inhibitors |
| 12/06/2007 | WO2007137833A1 Specifically adapted plant-derived redox catalyst and method for the production thereof |
| 12/06/2007 | WO2007137820A1 PYRIDO[3,2-e]PYRAZINES, THEIR USE AS INHIBITORS OF PHOSPHODIESTERASE 10, AND PROCESSES FOR PREPARING THEM |
| 12/06/2007 | WO2007137819A1 4-AMINO-PYRIDO[3,2-e]PYRAZINES, THEIR USE AS INHIBITORS OF PHOSPHODIESTERASE 10, AND PROCESSES FOR PREPARING THEM |
| 12/06/2007 | WO2007137808A1 Compositions comprising oligosaccharides for treating prion disease |
| 12/06/2007 | WO2007137590A1 Sertindole for the preventive treatment of suicidal behaviour |
| 12/06/2007 | WO2007137409A1 Treatment and prevention of cognitive decline |
| 12/06/2007 | WO2007115997A3 Combination preparations from modafinil, ritalin and topiramat for use in cocaine dependency and/or for treating impulse control disorders |
| 12/06/2007 | WO2007055773A3 Use of inhibitors of pi3k-c2a for the treatment of apoptos i s-related disorders |
| 12/06/2007 | WO2007038112A3 Combination of rosiglitazone and donepezil for improvement of cognitive function |
| 12/06/2007 | WO2003023001A3 Novel proteins and nucleic acids encoding same |
| 12/06/2007 | US20070282126 Novel Crystal Of Triterpene Derivative |
| 12/06/2007 | US20070282105 e.g. 3-[2-(4-aminophenyl)ethyl]-8-benzyl-7-(2-ethylamino)ethyl-1-propylxanthine; A1-adenosine receptor antagonist; antiallergen, antiinflammatory agent; AIDS and immune deficiency disorders, asthma; good water solubility |
| 12/06/2007 | US20070282017 Methods and compositions for treating and preventing neurologic disorders |
| 12/06/2007 | US20070282016 Methods and compositions for use of angiogenesis inhibitors in the prevention and/or control of epilepsy |
| 12/06/2007 | US20070282007 TREATMENT OF PAIN DISORDERS WITH trans 4-(3,4-DICHLOROPHENYL)-1,2,3,4-TETRAHYDRO-1-NAPHTHALENAMINE AND ITS FORMAMIDE |
| 12/06/2007 | US20070281974 1 h-imidazole derivatives as cannabinoid receptor modulators |
| 12/06/2007 | US20070281954 Cyclohexyl-1,4-diamine compounds |
| 12/06/2007 | US20070281952 Arylsulfonylnaphthalene Derivatives As 5Ht2a Antagonists |
| 12/06/2007 | US20070281948 Substituted 2-pyridone derivatives, method for their preparation and their use as medicament |
| 12/06/2007 | US20070281938 Inhibitors of 11-Beta-Hydroxy Steroid Dehydrogenase Type 1 |
| 12/06/2007 | US20070281937 Use of various imidazole compounds such as 2-(alkyl or (hetero)arylalkylthio)-imidazoles and S-oxides thereof to treat angina, hypertension, congestive heart failure, myocardial ischemia, arrhythmia, diabetes, urinary incontinence, stroke, pain, brain injury, or nervous system disorders |
| 12/06/2007 | US20070281936 To reducte the purinergic neurotransmission; Parkinson's disease; dyskinesias; Movement disorders; Adenosine receptors antagonists; 2-Methylamino-6-(5-methyl-2-furyl)-N-(2-pyridylmethyl)pyrimidine-4-carboxamide |
| 12/06/2007 | US20070281933 Novel Indazole Carboxamides And Their Use |
| 12/06/2007 | US20070281919 Aminothiazole Derivatives And Their Use As CRF Receptor Ligands |
| 12/06/2007 | US20070281906 Selective androgen receptor modulators for treating diabetes |
| 12/06/2007 | US20070281892 Dopaminergic Mimetics |
| 12/06/2007 | US20070281890 Fibroblast Growth Factor-13 |
| 12/06/2007 | US20070281027 Multilaminate backing construction |
| 12/06/2007 | US20070281012 Modified release formulations of a bupropion salt |
| 12/06/2007 | US20070281006 Methods And Compositions Comprising Supramolecular Constructs |
| 12/06/2007 | US20070280972 Adhesive solid gel-forming formulations for dermal drug delivery |
| 12/06/2007 | US20070280958 homodimer-forming chemokines such as Chemokine (C-C motif) ligand 2 (CCL2) having a single amino acid substitution in the dimerization interface that alters the pattern of hydrogen bonds; for inflammatory, autoimmune, or infectious diseases |
| 12/06/2007 | US20070280946 Antibody to 5' -Deoxy-5' - Methylthioadenosine And Uses Thereof |
| 12/06/2007 | US20070280934 Compositions and methods for treating cocaine-related disorders |
| 12/06/2007 | US20070280927 Treatment Of Neurodegenerative Diseases By The Use Of Atp7a |
| 12/06/2007 | US20070280911 Administering a probiotic composition comprising Bacillus subtilis, Bacillus coagulans and Enterococcus faecium,in a non-microencapsulated form; including a carrier such as fructooligosaccharides; dosage; physiological disorders; fungicides; nutrients;food additives; drugs |
| 12/06/2007 | US20070280886 Diagnostics and Therapeutics for Diseases Associated with Adrenomedullin Receptor (Amdr) |
| 12/06/2007 | DE202007002811U1 Biochemische Injektionsmittel Biochemical injectables |
| 12/06/2007 | DE102006025146A1 Peptide that modulates proteasome activity, e.g. for disease treatment, comprises a human protein sequence |
| 12/06/2007 | DE102006025103A1 Spezifisch adaptierter pflanzlicher Redoxkatalysator, als Mittel zur Behandlung von Stoffwechselveränderungen und immunbiologischen Zellbelastungsschwächen sowie Verfahren zu dessen Herstellung Specifically adapted plant redox catalyst, as agents for the treatment of metabolic changes and immune cell biological stress weaknesses and method for its manufacture |
| 12/06/2007 | CA2654033A1 Therapeutic agent for alzheimer's disease |
| 12/06/2007 | CA2653835A1 New use for cannabinoid |
| 12/06/2007 | CA2653818A1 Novel 1,4-diaza-bicyclo[3.2.2]nonyl oxadiazolyl derivatives and their medical use |
| 12/06/2007 | CA2653771A1 2-phenyl-5-amino-1,3,4-oxadiazoles and their use as nicotinic acetylcholine receptor ligands |
| 12/06/2007 | CA2653769A1 Novel 1,4-diaza-bicyclo[3.2.2]nonyl oxadiazolyl derivatives and their medical use |
| 12/06/2007 | CA2653681A1 Novel 1,4-diaza-bicyclo[3.2.2]nonyl pyrimidinyl derivatives and their medical use |
| 12/06/2007 | CA2653460A1 Novel 1,4-diaza-bicyclo[3.2.2]nonyl pyrimidinyl derivative and its medical use |
| 12/06/2007 | CA2653412A1 4-amino-pyrido[3,2-e]pyrazines, their use as inhibitors of phosphodiesterase 10, and processes for preparing them |